関連する実験動画
赤血球の分布幅と冠動脈疾患患者の心血管疾患発生率の関係
Marcello Tonelli1, Frank Sacks, Malcolm Arnold
1Division of Nephrology and Immunology, University of Alberta, 7-129 Clinical Science Building, 8440 112 St, Edmonton, Alberta T6B 2B7, Canada. no_reprints@med.ualberta.ca.
Circulation
|January 4, 2008
まとめ
赤血球分布幅 (RDW) の高さは,冠動脈疾患の患者の死亡率と心血管疾患の増加に関連しています. この発見は,RDWを初期に心不全がない人でも,潜在的なリスク指標として強調しています.
科学分野:
- 心臓病学 心臓病学
- 血液学 ヘマトロジ
- 臨床流行病学 臨床流行病学とは
背景:
- 赤血球分布幅 (RDW) の上昇は,心不全患者の不良結果に関連しています.
- 心不全のない冠動脈疾患患者のRDWの予後値については,さらなる調査が必要である.
研究 の 目的:
- ベースラインのRDWとあらゆる原因による死亡率および有害な心血管疾患の結果のリスクとの関連性を評価する.
- RDWが冠動脈疾患の個体における死亡率と心血管疾患の独立予測因子であるかどうかを判断する.
主な方法:
- コレステロールと再発性イベント (CARE) 研究データのポストホック分析.
- ランダムにプラバスタチンまたはプラセボを投与された4111人の参加者を含め,ベースラインRDW測定を行った.
- コックス比例リスクモデルを使用して,RDWと臨床結果の関係を分析し,平均59.7ヶ月のフォローアップ期間を記録しました.
主要な成果:
- ベースラインより高いRDWとすべての原因による死亡率の調整されたリスクの増加 (HR 増加率: 1.14%) の間に有意な関連性が見つかりました.
- RDW四分位数と死亡率との間には,段階的,独立した関係が観察された (P for trend=0.001),最も高い四分位数では死亡リスクが1.78倍増加した.
- また,高いRDWレベルは,冠動脈死亡/心筋梗塞,新しい心不全,脳卒中のリスクの増加と関連していました.
結論:
- 赤血球分布幅 (RDW) の高さは,独立して死亡や心血管疾患のリスクの増加と関連しています.
- RDWは,症状のある心不全がない場合でも,冠動脈疾患の患者の貴重な予後バイオマーカーとして役立つ可能性があります.
- これらの発見は,心不全の集団を超えて,心血管リスクの階層化におけるRDWのより広範な役割を示唆しています.
関連する概念動画
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...